Cabellon, Crispin B.
HRN: 21-53-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/10/2022
07/17/2022
IV
500mg
Q8h
GI Infection
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes